跳至主要内容
临床试验/CTRI/2025/10/095688
CTRI/2025/10/095688尚未招募2 期

Impact of Sthira kshirpaak on lactogenesis II of nursing Mothers and on weight velocity of their neonates A Randomized Controlled Trial

Dr Mithila Amin Shreeniwas2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年11月1日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
2
主要终点
Lactogenesis II time

研究概览

简要总结

Title

Impact of Sthira Kshirapaak on lactogenesis II in nursing mothers and on weight velocity of their neonates. A randomized controlled trial.

Introduction

Lactogenesis II is referred to as milk coming in which represents the onset of copious milk secretion, breast fullness and increased volume.

Need of the Study

Delayed Lactogenesis II with a global incidence of 17 to 44 percent has significant clinical implications on weight and growth outcomes of neonates.

Objectives

Primary

To assess the effect of Sthira on the duration of Lactogenesis II.

Secondary

To assess the impact of Sthira Kshirapaak administered to mothers on the weight velocity of neonates.

Materials and methods

Setting

Multi centric trial

Procedure

The dyad of mothers and neonates born in the maternity ward of the study centers screened for inclusion and exclusion criteria and willing to give an informed consent to participate in the trial will be registered.

PIS will be given to the participants and written informed consent/ assent will be taken and they will be randomized into 2 groups.

Assessment

Baseline data and periodic assessments will be done at the specified intervals. ie. Daily from day 1 of Post-partum until day 5 postpartum.

Objective Parameters

Expressed milk volume

Latch Score

Neonatal weight gain or loss per day

Test Weight

Subjective parameters

in mothers

based on Maternal perception of breast feeding

in neonates

based on

Satiety

urine frequency

stool frequency

etc.

Intervention

The Trial group will receive Sthira and Sita 6 grams each to be processed with milk while the Control group will receive Brown Cane Sugar and Sita 6 grams each also to be processed with milk. Both the intervention as well as placebo will have identical packing.

Duration of medication

5 days

Duration of the study

7 days

Ethical considerations

The study will commence after obtaining permission from the institutional ethical committee and after CTRI approval, following the GCP guidelines.

Statistical Analysis

Will be done using appropriate software.

References

Reference management systems will be used.

Conflicts of interest

Conflicts of interest if any shall be declared.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
15.00 Year(s) 至 49.00 Year(s)(—)
性别
Female

入选标准

  • For mothers: Registered Primi gravida mothers who have taken ANC.
  • In Reproductive age group of 15-49years.
  • Clinically Stable For Neonates: Live Singleton babies of either sex With birth weight appropriate for Gestational age Clinically Stable.

排除标准

  • For mothers: Contra-indicated to breast feed Those under medications that affect the study results Those with co-existing medical conditions that adversely affect lactation Those with major anatomical breast anomalies Critically ill For neonates Those with birth weights less than 2500grams or more than 3500 grams those with Gestational Age less than 37 weeks or greater than 42 weeks those with medical conditions which necessitate weaning or total parental nutrition Those with major congenital anomalies Critically ill neonates.

结局指标

主要结局

Lactogenesis II time

时间窗: Postpartum Day 1 to day 5 daily assessment

Latch Score in hours

时间窗: Postpartum Day 1 to day 5 daily assessment

次要结局

  • Neonatal weight loss or gain in grams(7 days)

研究者

发起方
Dr Mithila Amin Shreeniwas
申办方类型
Other [Individual Sponsor (Self)]
责任方
Principal Investigator
主要研究者

Dr Mithila Amin Shreeniwas

DY Patil School of Ayurveda

研究点 (2)

Loading locations...

相似试验